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Objectives: Most quality appraisal tools were developed for clinical medicine and tend to be
study-specific with a strong emphasis on risk of bias. In order to be more relevant to public
health, an appropriate quality appraisal tool needs to be less reliant on the evidence hi-
erarchy and consider practice applicability. Given the broad range of study designs used in
public health, the objective of this study was to develop and validate a meta-tool that
combines public health-focused principles of appraisal coupled with a set of design-
specific companion tools.
Study design: Several design methods were used to develop and validate the tool including
literature review, synthesis, and validation with a reference standard.
Methods: A search of critical appraisal tools relevant to public health was conducted; core
concepts were collated. The resulting framework was piloted during three feedback ses-
sions with public health practitioners. Following subsequent revisions, the final meta-tool,
the Meta Quality Appraisal Tool (MetaQAT), was then validated through a content analysis
of appraisals conducted by two groups of experienced public health researchers (MetaQAT
vs generic appraisal form).
Results: The MetaQAT framework consists of four domains: relevancy, reliability, validity,
and applicability. In addition, a companion tool was assembled from existing critical
appraisal tools to provide study design-specific guidance on validity appraisal. Content
analysis showed similar methodological and generalizability concerns were raised by both
groups; however, the MetaQAT appraisers commented more extensively on applicability to
public health practice.
Conclusions: Critical appraisal tools designed for clinical medicine have limitations for use
in the context of public health. The meta-tool structure of the MetaQAT allows for rigorousof Public Health, University of Toronto, Health Sciences Bldg, 6th floor, 155 College St.,
416 978 6064.
.ca (L. Rosella), Carolyn.bowman@oahpp.ca (C. Bowman), Beata.pach@oahpp.ca (B. Pach),
yfitzpatrick@ossu.ca (T. Fitzpatrick), Vivek.goel@utoronto.ca (V. Goel).
Elsevier Ltd on behalf of The Royal Society for Public Health. This is an open access article
tivecommons.org/licenses/by-nc-nd/4.0/).
p u b l i c h e a l t h 1 3 6 ( 2 0 1 6 ) 5 7e6 558appraisal, while allowing users to simultaneously appraise the multitude of study designs
relevant to public health research and assess non-standard domains, such as applicability.
© 2015 The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public
Health. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Box 1.
Definition of meta-tool for quality appraisal.
Meta-tool: a tool that orients the user to the appropriate
use of several appraisal tools and places them within a
larger framework to guide their use.Introduction
A standard approach to critical appraisal is essential to ensure
rigour and transparency. At a general level, critical appraisal is
the process of evaluating the trustworthiness, value, and
relevance of material1 and is often aided by a tool, intended to
guide the depth and breadthwhile increasing consistency and
transparency.1e6 Tools employ a variety of techniques
including question and answer format, checklist format,
numeric scales and summary scores. Additionally, compan-
ion tools may be used in the company of other design- or
method-specific tools to assess specific methodological ele-
ments. Overwhelmingly, appraisal tools have been developed
in the context of evidence-based medicine (EBM); wherein,
quality is predominantly determined according to the tradi-
tional study-design hierarchy and assessments of ‘risk of
bias’.2e4 To make evidence-informed decisions in public
health, evidence must be approached differently. Notably, the
traditional evidence hierarchy becomes less relevant as
randomised controlled trials, the most highly ranked form of
evidence in EBM, are often not feasible or ethical. Therefore,
the merit of specific study designs should be considered
within the context of the question. This approach more
appropriately addresses the heterogeneity of both evidence
and enquiries in public health.2,5,6 Further, a different scope of
considerations is required for appraisal in public health.2
Critical appraisal is traditionally focused on ‘risk of bias’,
which is highly appropriate for its origins in EBM, where high
internal validity is important to prove the efficacy of an
intervention. In public health, however, differences in setting
or context are also vital considerations. Therefore, the critical
appraisal approach must be able to adapt accordingly, given
study designs and applications relevant to public health
research and practice.
A useful appraisal tool requires a number of features.
Foremost, it must be able to adapt to a variety of purposes:
systematic review, topic enquiries, report updates, single
study appraisal, etc. The tool should be appropriate for
appraising different types of public health evidence: experi-
mental, observational, reviews, qualitative, grey literature,
etc. Third, it must apply across the spectrum of public health
topics, regardless of maturity; e.g. developing health issues or
emerging infectious diseases. Additionally, it must be suitable
for assessing either one item in isolation or reviewingmultiple
studies. Finally, it must create a detailed record of the process,
so that any inherent subjectivity of appraising is made
transparent and may be evaluated and communicated. There
are several challenges in developing a quality appraisal tool to
meet the above criteria. Most tools are design-specific and
focus only on ‘risk of bias’.7e11 Themodel of a ‘one tool fits all’
approach, however, is not only unlikely but also does notmake the best use of the existing science of quality appraisal,
nor does it adapt in the way articulated in the aforementioned
goals. However, this limitation may be overcome through the
use of a meta-tool; a tool which orients the user to the
appropriate use of several appraisal tools and places them
within a larger framework to guide their use (Box 1).
Thus, the meta-tool allows for tools with disparate ap-
proaches to be used within the same process, providing con-
sistency and transparency to the appraisal process. Further,
this approach allows the appraisal framework to be expanded
and relevant to public health.12 The meta-tool allows for wide
applicability and a high degree of flexibility, while maintain-
ing a rigorous and transparent process that is required to
conduct a detailed assessment.
The aim of this project was to develop a critical appraisal
meta-tool that would meet the contemporary needs of public
health researchers and practitioners who appraise and syn-
thesise evidence for the purpose of recommendations,
development of public health action, or scientific research.Methods
Search strategy
Two information professionals (SM, BP) undertook a literature
search with the goal of finding critical appraisal tools
commonly used in public health. An initial MEDLINE search
returned one relevant systematic review.7 The review refer-
ence list and subsequently those studies' reference lists were
hand-searched to identify additional tools, reviews, and other
relevant documents. A second Medline search was conducted
to identify tool comparisons, evaluations, and reviews pub-
lished subsequent to the initial systematic review.
A grey literature search was conducted of the following
organizational websites: The National Collaborating Centre
for Methods and Tools (NCCMT) repository of critical
appraisal tools, the Ontario Public Health Libraries Associ-
ation (OPHLA), the Canadian Agency for Drugs and Tech-
nology in Health (CADTH), the Joanna Briggs Institute, the
Cochrane Collaboration, the National Institute for Health
and Clinical Excellence (NICE) and the European Centre for
Disease Prevention and Control (ECDC). Library resources of
p u b l i c h e a l t h 1 3 6 ( 2 0 1 6 ) 5 7e6 5 59well-known North American and Australian universities
that grant degrees in medicine and public health were also
searched: University of Toronto, McMaster University, Me-
morial University, Yale University, John Hopkins University,
and the University of South Australia.
Selection criteria
The definition of tool was applied broadly; schemas and crit-
ical appraisal process documents were included. Tools were
excluded if they did not address internal validity. Tools were
included if they addressed a study design relevant to public
health practice.
Comparison of tool items and development of quality
framework
The selected critical appraisal tools were compared according
to individual items; similarities were collated. The OPHLA
critical appraisal guide,13 which builds on content created by
the Public Health Research, Education, and Development
Program (PHRED),14 was used as a starting point to categorize
concepts of quality for public health evidence.
Once all of the components of the tool were mapped, the
remaining questions on the toolswere examined to determine
whether they were relevant to appraising evidence in a public
health context. The overall framework was developed from
the domains that emerged from this mapping process. Pref-
erence was given to tools with documented validity and reli-
ability. To determine the level of acceptability and adoption,
the authors considered the presence of the tool on university
library recommended lists and evidence of use in public
health research.
Feedback sessions
The draft tool was tested during three feedback sessions.
Participants were members of a large public health organiza-
tion, who regularly provide technical and scientific advice on a
wide range of public health issues, and included various levels
of training and subject matter expertize.
One article was selected by the authors for the group to
appraise15 and participants were invited to bring a second
article from their area of work. Participants appraised the ar-
ticles using the draft tool, followed by a group discussion
focused on the interpretation of the tool elements. Three au-
thors (LR, BP, SM) recorded feedback; relevant suggestions
were identified and revisions were made accordingly.
Pilot testing and evaluation
The revised Meta Quality Assessment Tool (MetaQAT) was
then piloted within several scientific teams beginning in
November 2013. Pilot users were invited to share feedback in
interviews and data was analyzed thematically.
Validation
Several aspects of validity were considered: face validity (ap-
pears to measure the concept it reports to measure), contentvalidity (covers all aspects of the concept it reports to mea-
sure), and criterion validity (ability to classify according to an
agreed standard measure of the concept).16 Face validity was
assessed by consulting with senior scientists experienced in
critical appraisal. Content validity was established during the
development process, when the content of relevant tools was
compared and mapped according to a standard source. This
process ensures that the MetaQAT framework covers all as-
pects of critical appraisal addressed by existing tools. In
addition, the framework was compared with the Heller
framework for appraisal in public health.2 Since no gold
standard tool exists,7 criterion validity was assessed by expert
assessment of study quality.
A systematic process was designed to test validity. Specif-
ically, three journal articles that reflect a range of public health
issues were selected (Table 2).17e19 In order to remove variation
in journal characteristics such as quality and reporting stan-
dards, all articleswere selected from the same journal and year.
Academic research staff, experienced in critical appraisal, were
divided into two groups and asked to examine the articles for
quality and report on the strengths andweaknesses; one used a
generic critical appraisal feedback form and the other used
MetaQAT. The generic form consisted of the following appraisal
prompts: ‘What are the strengths of this study?’, ‘What are the
weaknesses of this study?’, ‘Comment on sources of bias’, and
‘Comment on overall quality’.
The unstructured critical appraisal forms were collected
and the content coded by CB, with TF acting as an indepen-
dent second coder.20 The codes were grouped by article and
were compared across reviewers. Reviewer responses were
discussed (CB, TF, LR) in order to decipher broad meanings
until consensus was reached. The resulting codebook was
reviewed by the study team, with only minor changes to
ensure consistent coding of epidemiological concepts. The
MetaQAT set of responses were then coded using the code-
book. Code groupings evolved and new codes were added to
match concepts expressed by group assigned the MetaQAT
tool. The coding was summarized both by participant and
appraisal group.
Content analysis was conducted using MAXQDA version
11.Results
Search and selection of tools
Thirty-six relevant tools were identified and included in the
item mapping process2,8,9,13,21e52 and included tools for sys-
tematic reviews, randomized controlled trials, observational
studies, cohort studies, economic evaluations, needs ana-
lyses, clinical guidelines, user studies, quantitative studies
(generic), qualitative studies, and mixed methods studies.
Item mapping outcome e critical appraisal framework
Through the mapping, a four-domain appraisal framework
was developed, consisting of relevancy, reliability, validity,
and applicability (Fig. A1). The tool provides generic guidance
on how to assess validity; instead, the user is guided to the
Table 1 e Design-specific companion tools.
Research design Recommended critical appraisal tool
Systematic reviews and meta-analyses Assessing the Methodological Quality of Methodological Reviews
(AMSTAR)9
Cohort studies Critical Appraisal Skills Program (CASP): Cohort Studies Checklist26
Case control studies Critical Appraisal Skills Program (CASP): Case Control Studies Checklist25
Economic evaluation studies Critical Appraisal Skills Program (CASP): Economic Evaluation Studies
Checklist27
Non-randomised controlled trials Transparent Reporting of Evaluations with Non-randomized Designs
(TREND)8
Randomised controlled trials Consolidated Standards of Reporting Trials CONSORT Statement47
Mixed methods research Evaluation Tool for Mixed Methods Studies42
Qualitative research McMaster Critical Review Form e Qualitative Studies40
Guidelines for Critical Review Form: Qualitative Studies
Clinical guidelines Appraisal of Guidelines, Research and Evaluation (AGREE II) Instrument22
p u b l i c h e a l t h 1 3 6 ( 2 0 1 6 ) 5 7e6 560companion set of existing, design-specific tools to provide
detailed questions to augment the generic tool (Table 1). It is
intended that the list of companion tools will continue to
evolve as new needs are identified and new tools are devel-
oped. The fourth domain, applicability, is vital to the utility of
the tool in public health. This domain asks the user to
consider the different ways that the evidence could be used in
public health; asking key questions to ensure all relevant
public health concepts, such as equity, have been considered.
This encourages the user to think beyond direct generaliza-
tion of the results and consider the application of the evidence
more broadly. Each domain consists of a main question with
one or two parts, including several supplementary ‘hint’
questionsmeant to guide the user. Space is provided to record
the answer to eachmain question. The answers are written in
long form, with optional tick boxes corresponding to yes, no,
unclear, or N/A. The long-form answer provides space for
documentation of the appraisal process; allowing response
reasoning to be recorded so that they can be later referred to
and evaluated. Relatedly, because the tool is intended to be
flexible and adaptable it is not prescriptive; many of the
questions in the main tool are intentionally broad and open
ended.Feedback sessions
Following feedback from the first two sessions, revisions were
made to increase usability and clarity. Participants of the third
feedback session had fewer questions and suggestions
regarding the revised tool; indicating that the revised version
was more acceptable to participants. Following the third ses-
sion, the authors (LR, BP, SM) discussed the three sessions and
made any final revisions.Evaluation
Preliminary results were used to clarify definitions of the do-
mains and reorganize questions to better align with the do-
mains. The main change concerned the terminology used,
which was revised to match accepted research usage of the
terms validity and reliability. The guide was rewritten to
include explanations and instructions for each part of the tool.Validation
A total of six summary tables (Appendix A1) were prepared.
Therewas a high degree of agreement between the two groups
on issues pertaining to validity; both groups of appraisers
identified and commented on issues of design, measurement,
confounding, selection bias, and external validity (Table 3).
Comments notably differed within the other domains,
particularly applicability. Furthermore, the MetaQAT group
tended to highlight specific items that were not reported or
not clear, potentially affecting both the overall appraisal and
bias assessment between MetaQAT and generic form users.
These differences are likely a result of the explicitness of the
relevancy and applicability domains within MetaQAT.Discussion
This study describes the rationale, development and valida-
tion of a new quality appraisal meta-tool for public health.
MetaQAT expands the process of appraisal from being pri-
marily focused on internal validity, to consider both the in-
ternal and external validity within the wider context of
application to public health practice. Importantly, we present
a transparent development and validation process, which is
notably missing from most quality appraisal documentation
and is an important aspect of deciding on the appropriateness
of a given tool. When searching for an appropriate tool for use
in our organization, we found ourselves facing two opposing
needs. First, the tool must be flexible enough to accommodate
the variety of enquires relevant to public health. This strongly
suggested a generic tool would be best. Alternatively, the need
for a rigorous process dictated the necessity of design-specific
instruments. The meta-tool concept came about as a way to
marry these two disparate needs. This conflict has been noted
by others,2,12 and the potential for companion tools to bridge
this gap has been previously suggested.12 This approach was
successful in creating a tool that is both flexible and specific,
enabling the user to appraise all types of evidence using a
single tool, without sacrificing the level of detail necessary for
a truly rigorous appraisal.2,12 Therefore, it was decided to use a
generic tool, accompanied by a set of companion tools for in-
depth validity assessment. Themapping process ensured that
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p u b l i c h e a l t h 1 3 6 ( 2 0 1 6 ) 5 7e6 5 61the framework was consistent with the coverage of quality
assessment in existing appraisal tools. Further development
of the framework involved clarifying the meaning and
coverage of each section through user feedback and
interviews.
MetaQAT is uniquely structured and, therefore, less com-
parable to other tools. To the best of our knowledge, there is
only one other appraisal tool designed specifically for use in
public health,2 although it is designed for individual studies
and was not validated, but piloted. Similar to MetaQAT, this
checklist has included additional aspects relevant to
appraising public health evidence, namely ‘transferability’.
Additionally, it is meant to be used within an alternative hi-
erarchy of evidence specific to public health, and accompa-
nied by the use of companion tools. Unlike MetaQAT,
however, this checklist does not explicitly guide the user in
assessing applicability; nor does it provide the user with a set
of companion study design-specific tools. Further, this
checklist was developed to be used in the appraisal of single
items, whereas MetaQAT may be used to appraise single or
multiple sources of evidence. Moreover, despite being deemed
‘useful’ by respondents during pilot examination, the check-
list did not demonstrate improved performance over other
tools.2 Validation of MetaQAT suggests notable enhance-
ments, particularly regarding references to applicability in
practice.
Validation of critical appraisal tools is difficult as there is
no established gold standard for any study design.7 We
decided to use a qualitative approach to validation. While it is
an innovative approach, we felt it best suited our situation.
Using content analysis allowed us to understand and catego-
rise the content of the appraisals and make meaningful
comparisons between the two participant groups. Unlikemost
appraisal tools, MetaQAT does not include a numeric score
and any attempt at quantifying appraisals done using
MetaQAT is discouraged. Through our literature review and
the tool's development, we recognized that the practice of
assigning numeric scores is particularly unsuited to
appraising public health evidence. Numeric scores obscure
key information regarding the strengths and weaknesses of
the evidence for public health practice. Even in situations
where a summary score would have some degree of utility,
their use should be discouraged as numeric summary scores
have been shown to be unreliable.2,12,53e56 Further, the ques-
tion and answer format of MetaQAT is designed to make it
accessible, particularly for novice appraisers. Including an
optional tick box to augment the long-form answer is meant
to help orient new users who are more familiar with that
format. However, the long-form answers will contain the key
strengths and weaknesses of the evidence, and therefore, the
information needed for thoughtful application of the evi-
dence. Quality assessments should be made using the
framework as a whole.
There are some limitations to be aware of when consid-
ering this study. Firstly, the search was initiated from an
existing systematic review of appraisal tools. This was done
because it was an efficient and practical way to begin identi-
fying potential tools. We believe that the subsequent Medline,
grey literature search and snowball searching from the orig-
inal review resulted in an acceptable coverage of existing
Table 3 e Highlights of similarities and differences between the MetaQAT (M) and generic form (F) appraisal group
assessments.
Study Similarities in main issues Differences in main issues
Selassie et al.  Multiple sources of selection bias:
/ Outcomemeasure not specific to sport,
resulting in misclassification: ‘e-codes
that mention sport are limited so that
only 1/3 of sports related injuries are
identifiable’ M7
/ Large exclusions based on activity
(‘excluded bike-related TBI’ M3) and
treatment location (‘missed TBI from
private physician offices, urgent care
facilities’ M7, ‘issues of access to care
for poorer individuals’ M1)
 Reliability and accuracy of hospital-
isation data and use of validated
measure:
/ ‘Hospital-based data……and national
administrative sources of population
data should be considered reliable’M1
/ ‘Objective validated outcome data
(administrative data)’ F1
 MetaQAT group reported differences
related to study setting and context,
such as types of sports and sport cul-
ture, which would affect the findings
/ ‘Would people in Ontario be just as
likely to play football like the study
population in South Carolina? It may
be hockey in Ontario.’ M7
 MetaQAT group considered applica-
tion within public health context as a
whole
/ ‘Severe TBI affect only small fraction of
population. Focus on TBI in general/
any sports TBImay bemore relevant to
public health’ M2
 Ethics procedures noted by MetaQAT
group only
Ojha et al.  Significant selection bias:
/ Multiple exclusions, not clearly docu-
mented: ‘lack of sufficient descriptions
on the percentage of subjects
remained in the study after applying a
number of exclusion criteria’ F4
/ ‘Important group excluded from the
studydthose who do not have a regu-
lar health care provider’ M4
 Differences between analysis groups
/ ‘Noted demographic differences be-
tween groups’ F3 and potential for
further unmeasured differences
 Important public health topic for study
/ ‘Accuracy of these proxy measure is
important to program planning’ M1,
‘applicable to a wide range of re-
searchers and practitioners’ F2
 Appropriate study design using na-
tionally representative sample,
applied population weights
 Appropriate use of gold standard
measure
 The MetaQAT group commented more
extensively and more specifically on
application, e.g. comparison of popu-
lation to local population, note to
consider the impact of using one dose
of vaccine vs full coverage
/ ‘Study population likely similar
enough to Ontario population’ M6
 Ethics procedures noted by MetaQAT
group only
Cocoros et al.  Residual and uncontrolled confound-
ing significant sources of bias
/ ‘Many opportunities for residual con-
founding’ F1
/ ‘Uncontrolled confounders draw
resulting associations into question’
M1
 External validity and selection bias is-
sues with very specific population
/ ‘Study results may not be general-
isable to women or outside this narrow
age range, or people with health
problems that would have exempted
them from the conscription examina-
tion’ F2
 Vague exposure measurement
/ ‘Limited scope, acute respiratory in-
fections are very common in US, most
not treated clinically’ M2
 MetaQAT group were more likely to
comment on the applicability of the
evidence and relate to public health
setting
/ ‘Not all that useful in the public health
context. Difficult to do a lotmore about
reasons for maternal and child hospi-
talisations. If this was done, effect on
obesity would be small’ M6
 Ethics procedures noted by MetaQAT
group only
p u b l i c h e a l t h 1 3 6 ( 2 0 1 6 ) 5 7e6 562
Table 3 e (continued )
Study Similarities in main issues Differences in main issues
/ ‘Exposure (hospitalisation for infec-
tion) is a poor proxy for what they are
truly interested in (infection)’ F1
 Small effect size
/ ‘Effect is so small’ M6
/ ‘Very wide confidence intervals for any
small effect size and therefore gener-
ally unconvincing results’ F3
p u b l i c h e a l t h 1 3 6 ( 2 0 1 6 ) 5 7e6 5 63critical appraisal tools. A recent review of appraisal tools used
a similar strategy as a practical and time-saving approach.57
Additionally, another large review of critical appraisal tools
found that an untraditional approach was required to identify
appraisal tools.10 Secondly, the primary use of MetaQAT is to
guide users in summarising the strengths and weaknesses of
individual items of evidence. By allowing the same tool to be
used across all types of evidence, MetaQAT overcomes the
challenges associated with summarising the collective
appraisal of a body of evidence. However, the challenge of
assessing a body of evidence goes further than the question of
which tool is used, and further work is required to fully
address this need. Finally, we recognise the need for further
validation and plan to conduct work outside of our organisa-
tion as the next step in establishing the validity of MetaQAT.
Conclusions
The MetaQAT fills a critical gap in appraisal tools available for
use in public health research and practice. This paper pro-
vides a clear description of the development, evaluation and
validation of this new tool. Validation among a group of public
health researchers and practitioners suggests that appraisals
of evidence completed using MetaQAT are comparable with
judgements of quality made using generic appraisal guides.
Appraisals completed using MetaQAT, however, expand
quality assessment to include considerations relevant to
public health, such as the application of the evidence to local
context. It is our hope that MetaQAT will support the use of
evidence beyond our organization, filling the critical appraisal
tool gap currently experienced by the wider public health
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